Lung Cancer Survival Rates Exceed National Averages*

As a National Cancer Institute-designated comprehensive cancer center whose focus is on treating cancer, City of Hope is proud to announce that our Lung Cancer and Thoracic Oncology Program is achieving superior outcomes.
We recognize that each patient, tumor and immune system is unique. With this understanding we determine a personalized course of treatment that will produce the best patient outcome. This individualized approach is combined with state-of-the-art screening, prevention, diagnostic technology and treatment, such as cost-effective, low-dose computed tomography scanning technology, robotic-assisted endoscopy technology, molecular and genetic testing, minimally invasive procedures and more.
When compared to other centers, patients treated for lung cancer at City of Hope had lower lengths of stay overall and the lowest unplanned readmission rates. After measuring our own outcomes, City of Hope surpassed SEER National Median Survival for Nonsmall Cell Lung Cancer at All Stages, as evidenced by the following data:

Download Lung Cancer Outcome Summary

Data were derived from the City of Hope Cancer Registry (CNeXT) and SEER November 2019 Disease Specific Data Files as the comparator. All City of Hope patients were diagnosed from 2007 through 2016, and the COH follow-up cutoff date was 12/31/2017, to align with SEER data. Survival time was based on first occurring nonsmall cell lung cancer diagnosis during the time period of interest.
An authoritative source on cancer incidence and survival, the SEER Program provides cancer statistics to reduce the cancer burden among the U.S. population. It is supported by the Surveillance Research Program, which provides national leadership in cancer surveillance, using analytical tools and methodological expertise in collecting, analyzing, interpreting and disseminating reliable population-based statistics.

Comprehensive Care Is the Key

Our multidisciplinary approach allows us to deliver complex, subspecialized care with a team comprised of:
  • Pulmonologists
  • Interventional pulmonologists
  • Thoracic surgeons
  • Thoracic oncologists
  • Pathologists
  • Geneticists
  • Radiation oncologists
  • Oncology nurses
  • Social workers
Whether receiving care at our state-of-the-art hospital in Duarte, California, or at one of our more than 35 cancer-focused locations in the Southern California region, patients have access to a broad suite of lung and airway health services, including precision screening and prevention services, leading-edge diagnostic technologies, superior treatments and additional programs that can meet each patient’s individual treatment needs and provide successful outcomes.

Request a consultation

To make an appointment or to get a second opinion consultation about your treatment, you may request an appointment online or contact us at 800-826-4673. Please visit Making Your First Appointment for more information.
You or your office may refer a patient by calling 800-COH-4DRS, Monday through Friday from 8 a.m. to 6 p.m. to speak with a patient referral specialist. After-hours calls will be answered within one business day.

*Based on SEER (Surveillance, Epidemiology, and End Results) National data